Sort
82,697 grants matching “vaccine development”
Core 5: Integrated Support Services
$1,824,565Ronald B Corley · Boston University Medical Campus · UC7 · FY2024 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,823,992Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
$1,823,674Benjamin Jacob Doranz · Integral Molecular · N01 · FY2011 · AI
Innate immune response to microbial infection
$1,823,475William Michael Nauseef · University Of Iowa · P01 · FY2014 · AI
Genome-wide hypermutation and structural instability
$1,823,473Dmitry Gordenin · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Reproductive Endocrinology And Infertility Clinical Training Program
$1,822,588James H. Segars · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$1,822,363Powel H Brown · University Of Tx Md Anderson Can Ctr · UG1 · FY2021 · CA
Colorado Head and Neck Cancer SPORE
$1,822,219Antonio Jimeno · University Of Colorado Denver · P50 · FY2022 · CA
NIAID PRECLINICAL DEVELOPMENT SUPPORT: Essential Core Activities
$1,821,904Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
HIV VACCINE CLINICAL TRIALS UNIT
$1,821,839Vanderbilt University · U01 · FY2002 · AI
Center for Research on Processes in Evolution
$1,821,558Larry J Forney · University Of Idaho · P20 · FY2008 · RR
Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens
$1,821,474Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2017 · AI
HIV VACCINE CLINICAL TRIALS UNIT
$1,820,497University Of Rochester · U01 · FY2001 · AI
Serious Hazards of Transfusion & Cellular Therapies: Mechanisms and Intervention
$1,820,356John D Roback · Emory University · P01 · FY2012 · HL
Host-pathogen competition in IFN mediated antiviral defense
$1,820,077Jae U Jung · University Of Southern California · U19 · FY2013 · AI
Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease
$1,819,769Cynthia Nau Cornelissen · Georgia State University · U19 · FY2020 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,818,913Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
The Molecular Pathogenesis of Varicella Zoster Virus Infection
$1,818,598Maria Acena Nagel · University Of Colorado Denver · P01 · FY2017 · AG
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES
$1,818,454Tyson Heilherker · Boston Children'S Hospital · N01 · FY2023 · AI
Respiratory Immunity Against Agents of Bioterrorism
$1,818,389Wake Forest University Health Sciences · P01 · FY2004 · AI
Innate immune response to microbial infection
$1,818,142William Michael Nauseef · University Of Iowa · P01 · FY2010 · AI
Mayo Clinic Ovarian Cancer SPORE
$1,818,053Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2024 · CA
Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs
$1,817,834Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · P01 · FY2021 · AI
Innate immune regulation of inflammation and adaptive immunity
$1,817,670Anthony L. Defranco · University Of California, San Francisco · P01 · FY2009 · AI
Colorado Head and Neck Cancer SPORE
$1,817,388Antonio Jimeno · University Of Colorado Denver · P50 · FY2023 · CA